The EANM guideline on radioiodine therapy of benign thyroid disease
Publication date
2023-09
Authors
Campennì, Alfredo
Avram, Anca M.
Verburg, Frederik A.
Iakovou, Ioannis
Hänscheid, Heribert
de Keizer, Bart
Petranović Ovčariček, Petra
Giovanella, Luca
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
cc_by
Abstract
This document provides the new EANM guideline on radioiodine therapy of benign thyroid disease. Its aim is to guide nuclear medicine physicians, endocrinologists, and practitioners in the selection of patients for radioiodine therapy. Its recommendations on patients’ preparation, empiric and dosimetric therapeutic approaches, applied radioiodine activity, radiation protection requirements, and patients follow-up after administration of radioiodine therapy are extensively discussed.
Keywords
Dosimetry, Fixed activity, Graves’ disease, Non-toxic goiter, RAI therapy, Toxic nodular goiter, Radiology Nuclear Medicine and imaging
Citation
Campennì, A, Avram, A M, Verburg, F A, Iakovou, I, Hänscheid, H, de Keizer, B, Petranović Ovčariček, P & Giovanella, L 2023, 'The EANM guideline on radioiodine therapy of benign thyroid disease', European Journal of Nuclear Medicine and Molecular Imaging, vol. 50, no. 11, pp. 3324-3348. https://doi.org/10.1007/s00259-023-06274-5